Niki BioSolutions, Inc.
NIKI
$9.57
-$0.30-3.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.64M | 1.48M | 1.39M | 1.43M | 1.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -170.90K | 68.00K | 62.00K | 196.60K | 331.20K |
| Total Operating Expenses | 1.82M | 1.52M | 1.62M | 2.04M | 2.45M |
| Operating Income | -1.82M | -1.52M | -1.62M | -2.04M | -2.45M |
| Income Before Tax | -1.38M | -1.84M | -1.95M | -3.05M | -4.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.38 | -1.84 | -1.95 | -3.05 | -4.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13.20K | -139.40K | -117.60K | -113.90K | -110.20K |
| Net Income | -1.36M | -1.98M | -2.07M | -3.17M | -4.27M |
| EBIT | -1.82M | -1.52M | -1.62M | -2.04M | -2.45M |
| EBITDA | -1.56M | -1.27M | -1.31M | -1.66M | -2.01M |
| EPS Basic | -1.86 | -3.12 | -3.53 | -5.70 | -7.87 |
| Normalized Basic EPS | -1.16 | -1.10 | -1.35 | -1.73 | -2.12 |
| EPS Diluted | -1.88 | -3.14 | -3.53 | -5.70 | -7.87 |
| Normalized Diluted EPS | -1.16 | -1.10 | -1.35 | -1.73 | -2.12 |
| Average Basic Shares Outstanding | 2.94M | 2.70M | 2.54M | 2.36M | 2.18M |
| Average Diluted Shares Outstanding | 2.94M | 2.70M | 2.54M | 2.36M | 2.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |